Comprehensive Decongestive Therapy as a Treatment for Secondary Lymphedema of the Lower Extremity and Quality of Life of Women After Gynecological Cancer Surgery

Lucia Kendrová; Wioletta Mikuľáková; Katarína Urbanová; Štefánia Andraščíková; Silvia Žultáková; Peter Takáč; Yuriy Peresta

doi:10.12659/MSM.924071

17 June 2020 : Clinical Research

Comprehensive Decongestive Therapy as a Treatment for Secondary Lymphedema of the Lower Extremity and Quality of Life of Women After Gynecological Cancer Surgery

Lucia Kendrová^1ABCDEFG*, Wioletta Mikuľáková^1ABEG, Katarína Urbanová^1BEF, Štefánia Andraščíková^2CDG, Silvia Žultáková^2EFG, Peter Takáč^3CDE, Yuriy Peresta^1DEF

DOI: 10.12659/MSM.924071

Med Sci Monit 2020; 26:e924071

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Pearson correlation analysis between improvement in QoL domains after CDT and baseline values of reduction LLL, PLL, pain, and age.

Δ LYMQOL	Age		Pain (VAS)		Reduction of LLL		Reduction of PLL
Δ LYMQOL	r	P	r	P	r	P	r	P
Δ Symptoms	−0.082	0.570	0.291		0.159	0.271	0.081	0.576
Δ Body age/appearance	0.087	0.546	0.167	0.247	0.114	0.433	0.125	0.387
Δ Function	0.132	0.359	0.362	0.010	0.024	0.868	−0.038	0.791
Δ Mood	−0.131	0.364	0.204	0.155	0.010	0.945	0.037	0.801
Δ Overall QoL	−0.254	0.076	−0.501		−0.125	0.386	−0.048	0.741
QoL – quality of life; CDT – complete decongestive therapy; LLL – lower limb lymphedema; VAS – Visual Analogue Scale; LYMQOL – Lymphoedema Quality of Life.

Back to the Article

Comprehensive Decongestive Therapy as a Treatment for Secondary Lymphedema of the Lower Extremity and Quality of Life of Women After Gynecological Cancer Surgery

Your Privacy